Skip to content
385 12385 12385 125 2 55 2 55 2 5

Drawing based on the label description. No photo yet.

“1,000 mg, red, oval-shaped, film-coated tablet, Printed on one side in white ink with the Boehringer Ingelheim company symbol and "385" on the top line and "12.5/2.5" on the bottom line”

385 12 5 2 5 pill

Pill with imprint 385 12 5 2 5 is red, oval, 19 mm and has been identified as Empagliflozin, Linagliptin, Metformin Hydrochloride 12.5 mg / 2.5 mg / 1000 mg. It is used for type 2 diabetes. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.

Empagliflozin, Linagliptin, Metformin Hydrochloride 12.5 mg / 2.5 mg / 1000 mg

Imprint
385 12 5 2 5
Strength
Empagliflozin 12.5 mg / Linagliptin 2.5 mg / Metformin Hydrochloride 1000 mg
Used for
Type 2 diabetes
Color
Red
Shape
Oval
Size
19 mm
Score
No score line
Form
Tablet, extended release
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc
Drug class
Diabetes medicine (SGLT2 inhibitor)
NDC
0597-0385, 0597-0385-86, 0597-0385-77, 0597-0385-88

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Empagliflozin, Linagliptin, Metformin Hydrochloride pills and guides

What is Empagliflozin, Linagliptin, Metformin Hydrochloride used for?

Empagliflozin, Linagliptin, Metformin Hydrochloride is used for type 2 diabetes.

Medicine type
Diabetes medicine (SGLT2 inhibitor); diabetes medicine (DPP-4 inhibitor)
Official uses from the US prescribing label

TRIJARDY XR is a combination of empagliflozin, linagliptin, and metformin hydrochloride (HCl) indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Empagliflozin is indicated to reduce the risk of cardiovascular (CV) death in adults with type 2 diabetes mellitus and established CV disease.

Limitations of Use

TRIJARDY XR is not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus. It may increase the risk of diabetic ketoacidosis in these patients.

TRIJARDY XR has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using TRIJARDY XR.

From the FDA-approved label on DailyMed (published Aug 25, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows 385 12 5 2 5. The parts can be split between the two sides, so turn the pill over and check both.
  • It is red, oval, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Trijardy XR.

Ingredients

Active: Empagliflozin, Linagliptin, Metformin Hydrochloride

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Empagliflozin, Linagliptin, Metformin Hydrochloride pills